Department of Bioinformatics and Biosciences, Capital University of Science and Technology, Islamabad, Pakistan.
J Biomol Struct Dyn. 2020 Jul;38(10):3003-3017. doi: 10.1080/07391102.2019.1650113. Epub 2019 Aug 5.
Pyrazinamide (PZA) is an important component of first-line anti-tuberculosis (anti-TB) drugs. The anti-TB agent is activated into an active form, pyrazinoic acid (POA), by (MTB) gene encoding pyrazinamidase (PZase). The major cause of PZA-resistance has been associated with mutations in the gene. We have detected several novel mutations including V131F, Q141P, R154T, A170P, and V180F (GeneBank Accession No. MH461111) in the gene of PZA-resistant isolates during PZA drug susceptibility testing followed by gene sequencing. Here, we investigated molecular mechanism of PZA-resistance by comparing the results of experimental and molecular dynamics. The mutants (MTs) and wild type (WT) PZase structures in apo and complex with PZA were subjected to molecular dynamic simulations (MD) at the 40 ns. Multiple factors, including root mean square deviations (RMSD), binding pocket, total energy, dynamic cross correlation, and root mean square fluctuations (RMSF) of MTs and WT were compared. The MTs attained a high deviation and fluctuation compared to WT. Binding pocket volumes of the MTs, were found, lower than the WT, and the docking scores were high than WT while shape complementarity scores were lower than that of the WT. Residual motion in MTs are seemed to be dominant in anti-correlated motion. Mutations at locations, V131F, Q141P, R154T, A170P, and V180F, might be involved in the structural changes, possibly affecting the catalytic property of PZase to convert PZA into POA. Our study provides useful information that will enhance the understanding for better management of TB. AbbreviationsDSTdrug susceptibility testingΔelecelectrostatic energyLJLowenstein-Jensen mediumMGITmycobacterium growth indicator tubesMTsmutantsMDmolecular dynamic simulationsMTBNALC-NaOH-acetyl-l-cysteine-sodium hydroxideNIHNational Institutes of HealthNPTamount of substance (N), pressure (P) temperature (T)NVTmoles (N), volume (V) temperature (T)PZasepyrazinamidaseΔpspolar solvation energyPTRLProvincial Tuberculosis Reference LaboratoryRMSDroot mean square deviationsRMSFroot mean square fluctuationsΔSASAsolvent accessible surface area energyTBtuberculosisGTotaltotal binding free energyΔvdWVan der Waals energyWTwild typeCommunicated by Ramaswamy H. Sarma.
吡嗪酰胺(PZA)是一线抗结核(抗 TB)药物的重要组成部分。结核分枝杆菌(MTB)基因编码的吡嗪酰胺酶(PZase)将抗结核药物激活为活性形式吡嗪酸(POA)。导致 PZA 耐药的主要原因与 基因中的突变有关。在进行 PZA 药物敏感性测试后,我们通过基因测序在 PZA 耐药分离株中检测到了几个新的突变,包括 V131F、Q141P、R154T、A170P 和 V180F(基因库登录号 MH461111)。在这里,我们通过比较实验和分子动力学的结果,研究了 PZA 耐药的分子机制。在 40ns 时,对 apo 和与 PZA 复合的突变体(MTs)和野生型(WT)PZase 结构进行了分子动力学模拟(MD)。比较了 MTs 和 WT 的均方根偏差(RMSD)、结合口袋、总能量、动态互相关和均方根波动(RMSF)等多种因素。与 WT 相比,MTs 达到了较高的偏差和波动。MTs 的结合口袋体积较小,而对接评分较高,而形状互补评分较低。MTs 中的残余运动似乎是反相关运动的主导。位置 V131F、Q141P、R154T、A170P 和 V180F 的突变可能涉及结构变化,可能影响 PZase 将 PZA 转化为 POA 的催化特性。我们的研究提供了有用的信息,将增强对结核病更好管理的理解。缩写词 DST 药物敏感性测试 Δelec 静电能 LJ Lowenstein-Jensen 培养基 MGIT 分枝杆菌生长指示剂管 MTs 突变体 MD 分子动力学模拟 MTBNALC-NaOH-乙酰-l-半胱氨酸-氢氧化钠 NIH 美国国立卫生研究院 NPT 物质的量(N)、压力(P)、温度(T)NVT 摩尔(N)、体积(V)、温度(T)PZase 吡嗪酰胺酶 Δpsp 极性溶剂化能 PTRL 省级结核病参考实验室 RMSD 均方根偏差 RMSF 均方根波动 ΔSAS 溶剂可及表面积能 TB 结核病 Gtot 总结合自由能 ΔvdW 范德华能 WT 野生型 由 Ramaswamy H. Sarma 传达。